Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Appointed director
|
|
SANGAMO THERAPEUTICS, INC (SGMO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/06/2023 |
4/A
| Duraibabu Prathyusha (SVP, CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 864 shares
@ $3.76, valued at
$3.2k
|
|
| 04/27/2021 |
4/A
| Duraibabu Prathyusha (VP, PFO and PAO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 345 shares
@ $12.27, valued at
$4.2k
|
|
| 04/27/2021 |
4/A
| Duraibabu Prathyusha (VP, PFO and PAO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Paid exercise price by delivering 1,863 shares
@ $11.19, valued at
$20.8k
Granted 13,750 shares
@ $0
Granted 27,500 options to buy
@ $11.19, valued at
$307.7k
|
|
| 06/03/2020 |
4/A
| Zakrzewski Joseph S (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $10.46, valued at
$209.2k
|
|
| 06/03/2020 |
4/A
| Smith Karen L. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $10.46, valued at
$209.2k
|
|
| 06/03/2020 |
4/A
| Ramasastry Saira (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $10.46, valued at
$209.2k
|
|
| 06/03/2020 |
4/A
| PARKER H STEWART (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $10.46, valued at
$209.2k
|
|
| 06/03/2020 |
4/A
| Meyers James R (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $10.46, valued at
$209.2k
|
|
| 06/03/2020 |
4/A
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $10.46, valued at
$209.2k
|
|
| 06/03/2020 |
4/A
| Carey Robert (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $10.46, valued at
$209.2k
|
|
| 02/27/2020 |
4/A
| LOEB GARY (EVP, General Counsel & Sec.) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 50,000 shares
@ $0
Granted 100,000 options to buy
@ $6.8, valued at
$680k
|
|
| 02/26/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/04/2017 |
4/A
| Herberts Curt A. III (Sr.VP & Chief Business Officer) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 13,433 shares
@ $16, valued at
$214.9k
Sold 3,197 shares
@ $16.7, valued at
$53.4k
Exercised 13,433 options to buy
@ $9.41, valued at
$126.4k
Exercised 781 options to buy
@ $9.41, valued at
$7.3k
Exercised 416 options to buy
@ $8.87, valued at
$3.7k
|
|
| 02/28/2013 |
4/A
| ANDO DALE G (VP, Therapeutic Dev. & CMO) has filed a Form 4 on SANGAMO BIOSCIENCES INC |
| 09/14/2011 |
4/A
| Gregory Philip D (CSO & Vice President, Research) has filed a Form 4 on SANGAMO BIOSCIENCES INC |
| 02/09/2009 |
4/A
| Mento Steven J (Director) has filed a Form 4 on SANGAMO BIOSCIENCES INC |
|
|